BBVA integrates ChatGPT into daily banking operations
BBVA is moving artificial intelligence from limited trials into everyday banking work by extending access to ChatGPT across almost its entire organisation.
BBVA is moving artificial intelligence from limited trials into everyday banking work by extending access to ChatGPT across almost its entire organisation.
The post Russian oil exports shift in November: Baltic surge counters southern collapse appeared first on Invezz
Oracle Corporation’s shares tumbled more than 6% in after-hours trading on Wednesday after fiscal second quarter revenue came in at $16.1 billion.
South Korea’s SK Hynix has confirmed that it is evaluating the possibility of a US stock market listing, a move that would
Global markets opened to a mix of risk aversion and corporate developments on Thursday as cryptocurrencies slid following renewed concerns around Federal
Google DeepMind is sharpening its scientific ambitions with a new automated research lab in the UK, signalling a broader push to tie
Vietnam’s National Assembly, on Thursday, took a significant step towards bolstering its nascent domestic rare earth processing sector by approving a revised
Scottish Mortgage share price popped this week, reaching its highest level since November 5. SMT jumped to a high of 1,140p, up
While current price charts indicate deteriorated optimism in crypto, the December 10 session confirmed staggering institutional appetite. Notably, investors poured substantial funds
SoftBank Group shares fell sharply on Thursday after Oracle’s weaker-than-expected quarterly results renewed worries about how long it will take for massive
JPMorgan Chase is preparing another expansion step in India, setting the stage for a fresh phase of growth in a country that
Oracle shares dropped 11% in premarket trading on Thursday, extending the previous session’s losses after the company reported quarterly results that underscored
Pfizer is rolling the dice again on an oral obesity pill.The pharmaceutical giant signed an exclusive global license agreement with YaoPharma, a
JPMorgan stock (NYSE: JPM) tanked nearly 5% on Tuesday after the bank’s consumer banking chief warned that 2026 expenses will reach $105